Literature DB >> 9881757

An intravascular chemoattractant lectin inhibits neutrophil migration.

M Sakamoto1, M Dias-Baruffi, R Santos-de-Oliveira, F Q Cunha, M C Roque-Barreira.   

Abstract

KM+, a lectin purified from Artocarpusintegrifolia seeds, is an attractant for neutrophils, and has properties similar to fMLP, IL-8 and MNCF. The endogenous lectin MNCF, inhibits carrageenan-induced neutrophil migration when intravenously administered in rats. In an attempt to mimic the activity of MNCF with KM+, we determined the effect of intravenous (iv) injection of KM+ (5 microg) on neutrophil migration to the peritoneal cavity of Wistar rats induced by KM+ (50 microg, intraperitoneal, ip), fMLP (5 ng, ip) and carrageenan (300 microg, ip). Initially we evaluated the effect of the time interval between intravenous and intraperitoneal administration of KM+. The intervals ranged from 20 to 120 min and progressively stronger inhibition was observed with increasing time intervals up to a maximum of 60 min, with effect decreasing thereafter. With injections at the optimum interval of 60 min, we observed that KM+ inhibited KM+- and carrageenan-induced neutrophil migration by 72%, and fMLP-induced migration by 56%. White cell counts for Wistar rats that only received KM+iv, performed at 0 to 120 min intervals after injection, revealed early neutropenia lasting 60 min, followed by a marked increase in circulating neutrophils that reached a maximum of twice the initial levels within 90 min and after 120 min returned to levels near to that observed before intravenous administration of KM+. These results indicate that when KM+ is present in the intravascular space, it produces an inhibitory effect on neutrophil migration similar to that caused by the intravenous administration of other chemoattractants, regardless of whether they act through a mechanism independent of carbohydrate recognition, as does IL-8, or are dependent on carbohydrate recognition, like MNCF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881757     DOI: 10.1023/a:1006947306260

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  9 in total

1.  Chemotaxis of neutrophil leukocytes towards substratum-bound protein attractants.

Authors:  P C Wilkinson; R B Allan
Journal:  Exp Cell Res       Date:  1978-12       Impact factor: 3.905

2.  Neutrophil chemotaxis in response to surface-bound C5A.

Authors:  R O Webster; B Zanolari; P M Henson
Journal:  Exp Cell Res       Date:  1980-09       Impact factor: 3.905

3.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

Review 4.  Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration.

Authors:  A Rot
Journal:  Immunol Today       Date:  1992-08

5.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  A neutrophil migration-inducing lectin from Artocarpus integrifolia.

Authors:  R Santos-de-Oliveira; M Dias-Baruffi; S M Thomaz; L M Beltramini; M C Roque-Barreira
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

7.  Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells.

Authors:  A Rot
Journal:  Cytokine       Date:  1992-09       Impact factor: 3.861

8.  Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism.

Authors:  A Rot
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

9.  FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

Authors:  D M Ornitz; A B Herr; M Nilsson; J Westman; C M Svahn; G Waksman
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

  9 in total
  1 in total

1.  Therapeutic administration of recombinant Paracoccin confers protection against paracoccidioides brasiliensis infection: involvement of TLRs.

Authors:  Ana Claudia Paiva Alegre-Maller; Flávia Costa Mendonça; Thiago Aparecido da Silva; Aline Ferreira Oliveira; Mateus Silveira Freitas; Ebert Seixas Hanna; Igor C Almeida; Nicholas J Gay; Maria Cristina Roque-Barreira
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.